Strongbridge Biopharma plc Reports First Quarter 2021 Financial Results and Provides Corporate ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Strongbridge Biopharma plc Reports First Quarter 2021 Financial Results and Provides Corporate ... Strongbridge Biopharma plcMay 12, 2021 GMT ~ Reports KEVEYIS ® (dichlorphenamide) First Quarter 2021 Revenue of $8.4 Million, a 25 Percent Increase Compared to $6.7 Million of Revenue During First Quarter of 2020 ~ ~ Reiterates Full-Year 2021 KEVEYIS (dichlorphenamide) Revenue Guidance of Approximately $34 Million to $36 Million ~ ~ Awaiting Day 74 Letter from U.S. Food & Drug Administration (FD...
Source: apnews.com